Melanin and chromoblastomycosis agents: Characterization, functions, and relation with antifungals. (12th February 2021)

• Record Type: Journal Article
• Authors: Koehler, Alessandra; Heidrich, Daiane; Pagani, Danielle M.; Corbellini, Valeriano A.; Scroferneker, Maria L.
• Is Part Of: Journal of basic microbiology. Volume 61:issue 3(2021)
• Page Start: 203
• Page End: 211
• Publication Date: 2021-02-12
• Subjects: chromoblastomycosis -- DHN‐melanin -- melanin -- tricyclazole; Microbiology -- Periodicals; 579
• DOI: 10.1002/jobm.202000664
• Languages: English
• ISSNs: 0233-111X

Abstract

Abstract: Melanins are a diverse group of dark pigments with similar properties. In fungi, the most studied is the dihydroxynaphtalene (DHN)‐melanin, present in several species including all the chromoblastomycosis agents, a chronic, disabling, and recalcitrant subcutaneous mycosis. It is synthesized in a pathway known as the pentaketide pathway, which has the agrochemical tricyclazole as an inhibitor, widely used in in vitro studies because it does not prevent the growth of fungi. There are different methodologies for qualitative and quantitative analyses of DHN‐melanin, which made it possible to discover its important structural and antioxidant functions, with melanin acting as a protective factor against the host's immune system. Also, it can interact with some of the main antifungals of medical interest, reducing its activity and the susceptibility of fungi to these agents. This review aims to discuss the aspects of DHN‐melanin, focusing on chromoblastomycosis, bringing the main findings of the published scientific studies, and highlighting the need for further research to understand this important fungal pathogenicity and a virulence factor.